Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUM.

Bhuiyan, Md S; Brintz, Ben J; Whitcombe, Alana L; Markmann, Alena J; Bartelt, Luther A; Moreland, Nicole J; Azman, Andrew S; Leung, Daniel T

Bhuiyan, Md S; Brintz, Ben J; Whitcombe, Alana L; Markmann, Alena J; Bartelt, Luther A; Moreland, Nicole J; Azman, Andrew S; Leung, Daniel T.

Bhuiyan MS; Division of Infectious Disease, University of Utah School of Medicine, Salt Lake City, UT, USA.
Brintz BJ; Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Whitcombe AL; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Markmann AJ; Maurice Wilkins Center, University of Auckland, Auckland, New Zealand.
Bartelt LA; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Moreland NJ; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Azman AS; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Leung DT; Maurice Wilkins Center, University of Auckland, Auckland, New Zealand.

Epidemiol Infect ; 150: e188, 2022 Nov 25.

Article in English | MEDLINE | ID: covidwho-2133091

Subject(s)

COVID-19; SARS-CoV-2; Humans; Seroepidemiologic Studies; COVID-19/epidemiology; Antibodies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Epidemiol Infect Journal subject: Communicable Diseases / Epidemiology Year: 2022 Document Type: Article Affiliation country: S0950268822001017

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google